Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Family Medicine · PACE, FL · NPI 1487608113
Verified facts
CMS Open Payments records show Daniel D Hickman, M.D. received $25.76 in general payments during 2025 across 1 reported records.
Dexcom, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $25.76 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $25.76 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $25.76 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 384 | 109 |
| Atorvastatin Calcium | Atorvastatin Calcium | 359 | 105 |
| Amlodipine Besylate | Amlodipine Besylate | 320 | 93 |
| Lisinopril | Lisinopril | 319 | 93 |
| Omeprazole | Omeprazole | 313 | 90 |
| Levothyroxine Sodium | Levothyroxine Sodium | 305 | 85 |
| Metformin Hcl Er | Metformin Hcl | 290 | 83 |
| Pantoprazole Sodium | Pantoprazole Sodium | 283 | 82 |
| Losartan Potassium | Losartan Potassium | 206 | 56 |
| Metoprolol Succinate | Metoprolol Succinate | 199 | 51 |
| Gabapentin | Gabapentin | 195 | 55 |
| Ezetimibe | Ezetimibe | 175 | 53 |
| Montelukast Sodium | Montelukast Sodium | 171 | 51 |
| Trazodone Hcl | Trazodone Hcl | 136 | 33 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 125 | 33 |
| Alprazolam | Alprazolam | 122 | 24 |
| Mounjaro | Tirzepatide | 120 | 17 |
| Tramadol Hcl | Tramadol Hcl | 120 | 18 |
| Allopurinol | Allopurinol | 119 | 33 |
| Meloxicam | Meloxicam | 117 | 33 |
| Duloxetine Hcl | Duloxetine Hcl | 112 | 29 |
| Furosemide | Furosemide | 106 | 36 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 101 | 26 |
| Zolpidem Tartrate | Zolpidem Tartrate | 101 | 15 |
| Metformin Hcl | Metformin Hcl | 96 | 29 |
| Tamsulosin Hcl | Tamsulosin Hcl | 96 | 33 |
| Pioglitazone Hcl | Pioglitazone Hcl | 94 | 29 |
| Pravastatin Sodium | Pravastatin Sodium | 86 | 24 |
| Escitalopram Oxalate | Escitalopram Oxalate | 85 | 26 |
| Potassium Chloride | Potassium Chloride | 81 | 29 |
| Diclofenac Sodium | Diclofenac Sodium | 78 | 25 |
| Glimepiride | Glimepiride | 78 | 22 |
| Jardiance | Empagliflozin | 77 | 16 |
| Celecoxib | Celecoxib | 75 | 20 |
| Finasteride | Finasteride | 74 | 24 |
| Simvastatin | Simvastatin | 74 | 22 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 72 | 11 |
| Hydrochlorothiazide | Hydrochlorothiazide | 67 | 22 |
| Metoprolol Tartrate | Metoprolol Tartrate | 66 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 63 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 63 | 24 |
| Sertraline Hcl | Sertraline Hcl | 63 | 15 |
| Famotidine | Famotidine | 60 | 16 |
| Lovastatin | Lovastatin | 57 | 15 |
| Carvedilol | Carvedilol | 54 | 18 |
| Bupropion Xl | Bupropion Hcl | 51 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 48 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 48 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 47 | 12 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 44 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 44 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 44 | 12 |
| Prednisone | Prednisone | 43 | 37 |
| Sucralfate | Sucralfate | 43 | 13 |
| Baclofen | Baclofen | 42 | 13 |
| Eliquis | Apixaban | 42 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 42 | 11 |
| Mirtazapine | Mirtazapine | 42 | suppressed |
| Synthroid | Levothyroxine Sodium | 41 | 12 |
| Benazepril Hcl | Benazepril Hcl | 38 | suppressed |
| Ozempic | Semaglutide | 38 | 11 |
| Topiramate | Topiramate | 38 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 37 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 37 | 13 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 34 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 33 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 32 | suppressed |
| Fenofibrate | Fenofibrate | 28 | suppressed |
| Temazepam | Temazepam | 28 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 27 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 27 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 26 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 24 | suppressed |
| Ibuprofen | Ibuprofen | 24 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 24 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 24 | suppressed |
| Pregabalin | Pregabalin | 23 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | 19 |
| Valacyclovir | Valacyclovir Hcl | 23 | 11 |
| Cefdinir | Cefdinir | 22 | 20 |
| Clonidine Hcl | Clonidine Hcl | 22 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 22 | 20 |
| Enalapril Maleate | Enalapril Maleate | 22 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 22 | suppressed |
| Spironolactone | Spironolactone | 22 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 21 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 21 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 20 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Clonazepam | Clonazepam | 19 | suppressed |
| Estradiol | Estradiol | 19 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 17 | suppressed |
| Ketoconazole | Ketoconazole | 17 | suppressed |
| Lorazepam | Lorazepam | 17 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 17 | suppressed |
| Methocarbamol | Methocarbamol | 17 | suppressed |
| Tradjenta | Linagliptin | 17 | suppressed |
| Amoxicillin | Amoxicillin | 16 | 11 |
| Azelastine Hcl | Azelastine Hcl | 16 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 16 | suppressed |
| Trulicity | Dulaglutide | 16 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 15 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | 14 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 15 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 15 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Chlorthalidone | Chlorthalidone | 14 | suppressed |
| Eszopiclone | Eszopiclone | 13 | suppressed |
| Januvia | Sitagliptin Phosphate | 13 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | 11 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 12 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 12 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 12 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 12 | 11 |
| Valsartan | Valsartan | 12 | suppressed |
| Atenolol | Atenolol | 11 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Testosterone | Testosterone | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $25.76 · 1 records | Dexcom, Inc. | Dexcom G6 Transmitter | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error